Eagle Strategies
ABBV icon

Eagle Strategies’s AbbVie ABBV Stock Holding History

Eagle Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$850K Sell
3,251
-11
-0.3% -$2.82K 0.08% 161
2026
Q2 		$821K Buy
3,262
+1,172
+56% +$252K 0.08% 158
2026
Q1 		$455K Buy
2,090
+423
+25% +$93.8K 0.05% 188
2025
Q4 		$381K Buy
1,667
+14
+0.8% +$3.19K 0.05% 195
2025
Q3 		$383K Sell
1,653
-81
-5% -$16.5K 0.05% 185
2025
Q2 		$322K Sell
1,734
-29
-2% -$5.39K 0.05% 185
2025
Q1 		$369K Sell
1,763
-4
-0.2% -$778 0.06% 157
2024
Q4 		$314K Sell
1,767
-73
-4% -$13.4K 0.05% 173
2024
Q3 		$363K Sell
1,840
-47
-2% -$8.77K 0.07% 156
2024
Q2 		$324K Sell
1,887
-9,617
-84% -$1.59M 0.06% 162
2024
Q1 		$2.09M Buy
11,504
+9,574
+496% +$1.65M 0.47% 55
2023
Q4 		$299K Buy
1,930
+20
+1% +$2.92K 0.06% 159
2023
Q3 		$285K Sell
1,910
-590
-24% -$86.6K 0.07% 152
2023
Q2 		$337K Buy
2,500
+1
+0% +$147 0.08% 141
2023
Q1 		$398K Buy
2,499
+173
+7% +$26.4K 0.1% 126
2022
Q4 		$376K Buy
2,326
+290
+14% +$44.5K 0.11% 116
2022
Q3 		$273K Buy
+2,036
New +$292K 0.14% 83

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Eagle Strategies's ABBV Position: Q3 2026 in Review

Eagle Strategies reduced its AbbVie (ABBV) stake by 0.34% in Q3 2026, selling an estimated $2.82K and leaving 3,251 shares worth $850K. The position accounts for 0.08% of the portfolio, ranked #161.

Eagle Strategies first reported a position in ABBV in Q3 2022 and has held it in 17 quarters since. The position peaked at $2.09M in Q1 2024. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Eagle Strategies held 3,251 shares of AbbVie worth $850K as of Q3 2026.
  • Eagle Strategies sold 11 AbbVie shares in Q3 2026, an estimated $2.82K.
  • AbbVie made up 0.08% of Eagle Strategies's portfolio in Q3 2026, its #161 holding.
  • Eagle Strategies first reported a position in AbbVie in Q3 2022 and has held it in 17 quarters since.
  • Eagle Strategies's AbbVie position peaked at $2.09M in Q1 2024.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Eagle Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.